1. Piperlongumine (piplartine) as a lead compound for anticancer agents – Synthesis and properties of analogues
   Kamil Piska et al, 2018, European Journal of Medicinal Chemistry CrossRef
2. Transcriptome Analysis of Piperlongumine-Treated Human Pancreatic Cancer Cells Reveals Involvement of Oxidative Stress and Endoplasmic Reticulum Stress Pathways
   Harsharan Dhillon et al, 2016, Journal of Medicinal Food CrossRef
3. Dual-specificity Phosphatase 1 Deficiency Induces Endometrioid Adenocarcinoma Progression via Activation of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Pathway
   Yuan Yang et al, 2016, Chinese Medical Journal CrossRef
4. JNK inhibition blocks piperlongumine-induced cell death and transcriptional activation of heme oxygenase-1 in pancreatic cancer cells
   Jiyan Mohammad et al, 2019, Apoptosis CrossRef
5. The role of MAPK signaling pathway in the Her-2-positive meningiomas
   Zhaoyin Wang et al, 2016 CrossRef
6. Effects of Hylomecon vernalis ethanol extracts on cell cycle and apoptosis of colon cancer cells
   Jing Sun et al, 2017 CrossRef
7. Piperlongumine induces apoptosis and G2/M phase arrest in human osteosarcoma cells by regulating ROS/PI3K/Akt pathway
   Jinfeng Zhou et al, 2020, Toxicology in Vitro CrossRef
8. Caffeine and its main targets of colorectal cancer
   Wen-Qi Cui et al, 2020, WJGO CrossRef
9. Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent
   Surya Kant Tripathi et al, 2020, Pharmacological Research CrossRef
10. Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells
    Cinara O. D’Sousa Costa et al, 2017, Oncotarget CrossRef
11. Discovery of piperlongumine as a potential novel lead for the development of senolytic agents
    Yingying Wang et al, 2016, Aging CrossRef
12. Natural Health Products (NHP’s) and Natural Compounds as Therapeutic Agents for the Treatment of Cancer; Mechanisms of Anti-Cancer Activity of Natural Compounds and Overall Trends
    Benjamin Scaria et al, 2020, IJMS CrossRef
13. Piperlongumine Alleviates Mouse Colitis and Colitis-Associated Colorectal Cancer
    Jia-Rong Huang et al, 2020, Front. Pharmacol. CrossRef
14. null
    Daniel Pereira Bezerra, 2021 CrossRef
15. Synthesis, in vitro cytotoxicity, and molecular docking study of novel 3, 4‐dihydroisoquinolin ‐1( 2 H )‐one based piperlongumine analogues
    Mahesh R. Kulkarni et al, 2021, J Heterocyclic Chem CrossRef
16. The promising potential of piperlongumine as an emerging therapeutics for cancer
    Dey Parama et al, 2021 CrossRef
17. Piperlongumine, a Potent Anticancer Phytotherapeutic, Induces Cell Cycle Arrest and Apoptosis In Vitro and In Vivo through the ROS/Akt Pathway in Human Thyroid Cancer Cells
    Fang-Ping Kung et al, 2021, Cancers CrossRef
18. Human Serum Albumin-based Propulsive Piperlongumine-loaded Nanoparticles: Formulation development, characterization and anti-cancer study
    Krunal Patel et al, 2022, Colloids and Surfaces A: Physicochemical and Engineering Aspects CrossRef
19. Synthesis, Characterization and Biological Evaluation of New Enamide Fluorinated‐Schiff Base Derivatives as Potential Cytotoxic and Apoptosis‐Inducing Agents
    Hany M. Abd El‐Lateef et al, 2023, ChemistrySelect CrossRef